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[3H]Tryptophan was initially incorporated into acid-ethanol-extractable protein, which on gel filtration was eluted with a molecular weight ofabout 9000 and contained a small amount of glucagon immunoreactivity. With longer incubation [3H]tryptophan incorporation into a second peak was obtained in an identical position with that of the majority of rat glucagon immunoreactivity. This peak of labelled protein exhibited migration characteristics on polyacrylamide-gel electrophoresis identical with those of rat glucagon and was identified as newly synthesized glucagon by demonstration ofspecific binding and dissociation behaviour with glucagon antibodies. They were unable to demonstrate significant immunoreactivity in this larger molecule, nor was it found possible to incorporate [3H]leucine into fish glucagon in either the presence or the absence of glucose. Tung & Zerega (1971) reported the incorporation of labelled tryptophan into bird glucagon and highermolecular-weight proteins in isolated pigeon islets. It appeared that in this system all tryptophan incorporation was virtually abolished by high concentrations of glucose.
Little is known of the pattern and control of glucagon secretion and ofthe storage ofthe hormone, and nothing is known of the mechanism of glucagon biosynthesis in mammalian systems. The biosynthesis of glucagon in mammalian islets isolated with collagenase appears to be extremely difficult to accomplish considering the ease with which insulin can be synthesized in these islets. Biosynthesis of glucagon in vitro was therefore undertaken in a recirculated perfused rat pancreas preparation.
Materials
Sephadex G-50 and G-75 (Gey & Gey, 1936) , supplemented with dextran (4%, w/v), and Trasylol (1000 Kallikrein inactivator units/ ml). All protein amino acids at a concentration of 10,g/ml, excluding the radioactive amino acid under study, were added to lOOml of the perfusate. Tryptophan (present in all known glucagons but no known proinsulin or insulin) (25Ci/mmol) and L-[3H]leucine (5OCi/mmol) were used at a concentration of 250,Ci in lOOml of perfusate. Glucose was added to a concentration of 1.67mm in the majority of experiments. Penicillin (100 units/ml) was added to perfusate used for incubations of more than 2h. The perfusate was gassed continuously with 02 +C02 (95:5), which was moistened by bubbling through water. The pancreas and perfusate were maintained at 37°C by means of a Dubnoff metabolic shaker bath. The perfusate was continuously circulated from the perfusate reservoir through the pancreas by means of a Serva peristaltic pump, which maintained pulsed flow at a rate of 5ml/min. pH monitoring throughout initial experiments indicated that a constant pH of 7.4 was maintained in this system. The pancreas was cleared of blood by preincubation for 30min with perfusate containing 1 .67mM-glucose without recirculation. After incubation the pancreas was washed for 30min by perfusion with perfusate containing 16.7mM-glucose to remove the majority of unincorporated radioactivity and at the same time to minimize glucagon secretion. Up to three pancreas preparations were perfused simultaneously.
The isolated perfused pancreas system was tested for glucagon release during a recirculated perfusion. The medium was sampled at 15min intervals for 4h into an equal volume of glucagon-assay buffer and immediately deep-frozen at -80°C until assayed. A cumulative linear release of glucagon was demonstrated. A linear increase in incorporation of radioactivity into acid-ethanol-soluble protein was obtained for more than 4h thus demonstrating viability of the preparation under the experimental conditions employed.
Perfusion ofpancreas ofstreptozotocin-diabetic rat
Male rats (200g) were rapidly injected intravenously with 13.5mg of streptozotocin (kindly supplied by Upjohn Ltd., Crawley, Sussex, U.K.) in 1 ml ofacid saline (0.3 g of O-cresol and lOml of 1 M-HCl/litre of 0.9 % NaCl). The animals were left 36h before operation and fed ad libitum before being starved overnight. Controls were injected with acid saline alone. The operative and pancreas perfusion techniques remained unaltered.
Extraction procedure
The perfused pancreata were extracted by the method of Kenny (1955) for glucagon. The pancreas was dissected free of extraneous tissue and ligatures, homogenized in acid-ethanol (750ml of ethanol, 250ml of water and 5ml of conc. HCI) by using a Willems polytron (Kinematica G.m.b.H., Lucerne, Switzerland) homogenizer and extracted overnight at 4°C. Two re-extractions with acid-ethanol for 1 h and Ih respectively were followed by adjustment of the pooled supernatants to pH7.5 with aq. NH3 (sp. gravity 0.880) and centrifugation to remove the residue. Protein was precipitated by alcohol-ether (6.8ml of ethanol and 11.2ml of diethyl ether/4ml of extract) overnight at 4°C. The precipitate was recovered by centrifugation and dried by vacuum desiccation at 4°C. The residue was dissolved in 9ml of chloride-phosphate buffer (200ml of 0.1 MNa2HPO4, pH7.4, and 800ml of 0.9% NaCl/litre) and dialysed against 10 litres of the same solution for 48h at 4°C. The dialysis residue was then freeze-dried and the residue taken up in 1.5ml of 1 M-acetic acid in preparation for gel filtration.
Gelfiltration
Gel filtration of labelled pancreas extract was carried out in 1 M-acetic acid on columns (1.6cm x 70cm) of Sephadex G-50 (superfine grade) at 4°C.
Refractionations were carried out on columns of 0.9cm x 30cm. Flow rate was adjusted to 4ml/h and the eluate was collected in 15 drop fractions (-0.8ml), or 10 drops (n0.5ml) for the smaller columns in an LKB Ultrorac fraction collector. Protein was determined by a Uvicord II absorptiometer connected to an LKB chopper-bar recorder, or by micro-Lowry protein assay (Lowry et al., 1951) with bovine serum albumin as standard protein. The void-volume peak fraction contained less than 75,ug of protein. Columns were calibrated with bovine serum albumin, cytochrome c, bovine insulin, bovine/ porcine glucagon and 1251-or Cl-, the last being detected by AgNO3. Marker proteins were not added to pancreatic extracts because of uncertainties introduced by non-specific absorption ofradioactive amino acid. Similarly, '311-labelled protein markers were not added because of uncertainties introduced when counting for 3H in the presence of 1311. Radioimmunoassays of insulin and glucagon were used as internal calibration markers during test-extract filtrations. Samples (0.5ml) ofalternate fractions from 70cm columns and 0.4ml samples of all fractions from 30cm columns were mixed with lOml of NE 220 scintillant and radioactivity was measured in a Nuclear Enterprises automatic liquid-scintillation spectrometer. Radioactivity was measured until sufficient counts had accumulated to give a counting error of ±5% after subtraction of the background count.
Electrophoresis
The peaks were pooled, freeze-dried and resuspended in 0.2ml of 0.O1M-HCl-15% (w/v) has an approximate molecular weight of 66000 and elutes at the void volume. Cytochrome c, molecular weight 12400, and bovine insulin, molecular weight 5750, elute in the positions indicated. Bovine/porcine glucagon, molecular weight 3480, elutes approx. 10.5ml after insulin on a 70cm column and approx. 2ml after insulin on a 30cm column.
Calibration of the experimental extract was obtained from the insulin and glucagon immunoassays of the proffle. Insulin immunoassay indicated the elution volumes of rat insulin and rat proinsulin.
Glucagon immunoassay of alternate fractions of eluate indicated two peaks of glucagon immunoreactivity (Fig. 1) ; rat glucagon identical with bovine/ porcine glucagon of molecular weight 3480 and rat pancreatic large glucagon of molecular weight similar to rat proinsulin, molecular weight approx. 9000. After rechromatography on a 0.9cm x 30cm column, the large [3H]tryptophan peak (fractions 100-125, Fig. 1 ), re-eluted in the position of the large glucagon of pancreatic origin (Fig. 2a) . Refractionation of the glucagon peak area (fractions 126-138, Fig. 1 ), gave a well-resolved peak of [3H]-tryptophan incorporation eluting in an identical position with that of rat glucagon (Fig. 2b) .
The identification of the [3H]tryptophan peak eluting in the glucagon-marker position was established as newly biosynthesized rat glucagon by incubation of the pooled fractions with glucagon antiserum and separation of antibody bound from free glucagon by gel filtration. 3H radioactivity was shifted from the glucagon elution position to the void volume of the column, the elution position of an antibody complex (Fig. 3a) . Incubation of the antibody complex so formed with 0.1 M-HCI for 16h dissociated the majority of the glucagon, which was then re-eluted in the position of glucagon (Fig. 3b) .
Pattern of [3H]leucine incorporation into protein
[3H]Leucine incorporation in the presence of zero glucose (Fig. 4a) incorporation. Glucagon immunoassay of this peak demonstrated that simultaneously the large-glucagon immunoreactivity had been further purified.
Effect of cycloheximide and glucose concentration on [3H]tryptophan incorporation
In the presence of cycloheximide, a specific inhibitor of protein synthesis at the ribosome level, [3H]tryptophan incorporation was markedly inhibited (Fig. 5 ). The addition of 11 mM-and 16.7mM-glucose decreased incorporation into both peaks, this effect being more marked at the higher concentration. Vol. 134
At the same time increased incorporation of radioactive tryptophan occurred into excluded protein (compare Figs. 1 and 5) . Perfusion of pancreas of streptozotocin-diabetic rat with [3H]tryptophan in the presence of 16.7mM-glucose gave an incorporation pattern comparable with low glucose incorporation (results not shown).
Polyacrylamide-gel electrophoresis Rat [3H]glucagon was subjected to electrophoresis on polyacrylamide gel and the radioactivity and glucagon immunoreactivity of the sliced gels determined. the same position as rat glucagon immunoreactivity and large-glucagon immunoreactivity (results not shown). When extended electrophoresis times were used, glucagon migrated to the positive (bottom) end of the gel. Under these conditions the large peak migrated only a small distance further into the gel (Fig. 6c) .
Discussion
Results presented here indicate that rat pancreas perfused in vitro incorporates [3H]tryptophan into acid-ethanol-extractable proteins eluting in the position of large glucagon and more slowly into a protein eluting in a position characteristic of glucagon. The identification of the latter protein as newly synthesized rat glucagon is based on the following observations. The synthesized material is extracted by the method of Kenny (1955) , a standard glucagonextraction procedure; tryptophan, a rare amino acid, present in glucagon is actively incorporated; the synthesized material elutes in a position identical with that of the majority of rat glucagon immunoreactivity; incorporation is decreased by the presence of cycloheximide and high concentrations of glucose; on gel electrophoresis it migrates to the same position as glucagon and is not separable from the glucagon immunoreactivity. Finally, the synthesized material was positively identified as newly synthesized rat glucagon by demonstration of specific binding to glucagon antibodies and the dissociability of the complex by low pH. Gastrin of pancreatic origin which contains tryptophan elutes later than glucagon The synthesized [3H]tryptophan peak containing large-glucagon immunoreactivity had a molecular weight comparable with that of rat proinsulin. This material appears to be synthesized in a way similar to that of rat glucagon in the presence of cycloheximide and high concentrations of glucose. It migrates on gel electrophoresis in a similar position to that of glucagon on 5cm gels unless extended running times are employed. The molecule is then less electronegative than glucagon. This synthesized material can also be partially bound by, and dissociated from, glucagon antibodies (see Fig. 3b) .
A time-lag of about 4h occurs before [3H]tryptophan incorporation into glucagon can be detected. This observation may be explained either in terms of technical difficulties (i.e. the presence of just one tryptophan residue in the molecule, the relatively low specific radioactivity of the labelled amino acid, etc.), or by the existence of a precursor with slow or retarded conversion in the biosynthesis of glucagon.
High concentrations of glucose impaired [3H]-tryptophan incorporation into both the largeglucagon-immunoreactivity area and the glucagon area. Thus high concentrations of glucose may inhibit glucagon biosynthesisperse, or, as suggested by the streptozotocin results, via an insulin-mediated step. This latter possibility requires further substantiation.
In contrast with insulin biosynthesis, which is virtually eliminated in the absence of glucose (K. J. O'Connor, A. Gay & N. Lazarus, unpublished work), optimum glucagon biosynthesis appeared to occur at low (or zero) concentrations of glucose. Incorporation of leucine into glucagon occurred in the presence of zero glucose whereas leucine was preferentially utilized for insulin biosynthesis in the presence ofhigh concentrations of glucose.
Investigations into the nature of the synthesized peak containing large-glucagon immunoreactivity should help to define whether a precursor-product relationship exists in the biosynthesis of glucagon or whethertwo separate hormonalentitieswithglucagon-
